We can offer a discount on bulk orders. Please contact our sales team for further inquiry.
Product Infomation
Product Name rosuvastatin-CY5.5@LNP-CAQK, rosuvastatin-CY5.5 fluorescently labeled lipid nanoparticles-CAQK targeting peptide complex
Catalog Number R-CW-LLCC01
Alias CY5.5-rosuvastatin-LNP-CAQK targeting nanoparticles
Appearance blue fluorescent colloidal solution
Molecular Formula N/A
Solubility Soluble in organic solvents
Storage -20°C, protected from light
Purity 95%+
Shelf Life 1 year
Shipping Condition low temperature transport
Application targeted delivery
Specification 10mg：Inquiry
25mg：Inquiry
50mg：Inquiry
Description rosuvastatin-CY5.5@LNP-CAQK is a multifunctional targeted drug delivery system. Rosuvastatin can inhibit cholesterol synthesis and lower blood lipids. It is often used for treatment of cardiac blood vessel diseases. CY5.5 is a near-infrared fluorescent dye that can achieve fluorescence imaging tracking in vivo and in vitro. Lipid nanoparticles (LNP) are composed of ionizable cationic lipids, phospholipids, etc., which can encapsulate rosuvastatin and CY5.5, protect their stability, and extend circulation time. CAQK peptide is a targeting peptide that can bind to matrix metalloproteinases in endothelial cells of damaged Blood vessels, guiding the system to accurately target the diseased site. This system combines the advantages of drug therapeutic effect, fluorescent tracing and targeted delivery. It has obvious potential in the diagnosis and treatment of diseases such as atherosclerosis. It can improve drug efficacy and reduce side effects. It can also monitor drug distribution and therapeutic effect through fluorescence.
Online Inquiry
For Research or Industrial Raw Materials, Not For Personal Medical Use!
Place the Order
FAQs
logo

Enter your email here to subscribe.

Copyright © MATEXCEL. All Rights Reserved.
0
Inquiry Basket